The aim of this study was to understand whether blood biomarkers such as pro-inflammatory markers (i.e., C reactive protein, CRP) and cytokines (i.e., IFN-I) could predict lung fibrosis-like changes in PC patients. This evidence concerns the gene CRP and pachyonychia congenita.